Showing all 8 results
Darifenacin Prolonged Release Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Prolonged-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Darifenacin Hydrobromide USP/Ph.Eur.
(Equivalent to Darifenacin base)7.5 mg (PR) The Standard Titration & Geriatric Anchor: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients to control OAB symptoms with minimal side effects. Darifenacin Hydrobromide USP/Ph.Eur. 15 mg (PR) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for patients who require greater symptom relief and have demonstrated high tolerability to the 7.5 mg dose. Excipients Hypromellose (HPMC) / Dibasic Calcium Phosphate / Magnesium Stearate / Polyethylene Glycol / Titanium Dioxide / Premium Polymeric Film Hydrophilic PR Matrix / Diluent / Lubricant / Plasticizer / Opaque Film (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastrointestinal fluids, the tablet hydrates to form a thick, gelatinous outer layer that strictly controls the diffusion of the highly soluble hydrobromide salt over a 24-hour period) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urological dispensing regimens).
Desvenlafaxine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Extended-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical and physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Desvenlafaxine Succinate USP/Ph.Eur.
(Equivalent to Desvenlafaxine base)50 mg (ER) The Global Therapeutic Standard: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients suffering from Major Depressive Disorder. Desvenlafaxine Succinate USP/Ph.Eur. 100 mg (ER) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for severe, treatment-resistant depression where maximum norepinephrine reuptake inhibition is required. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Talc / Magnesium Stearate / Premium Polymeric Film Hydrophilic ER Matrix / Diluent / Glidant / Lubricant / Film-Coating (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastric fluid, the tablet forms a thick, gelatinous outer layer that slowly erodes over 24 hours, guaranteeing a smooth, flat pharmacokinetic curve to prevent violent nausea and serotonin spikes) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day psychiatric dispensing regimens).
Oxybutynin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE desiccant bottles to ensure the absolute chemical stability of the controlled-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Oxybutynin Chloride USP/Ph.Eur. 5 mg (ER) Initiation Standard: Base once-daily titration unit for the gradual introduction of antimuscarinic therapy. Oxybutynin Chloride USP/Ph.Eur. 10 mg / 15 mg (ER) Global Clinical Standard: Advanced maintenance doses for severe, refractory Overactive Bladder and neurogenic detrusor overactivity. Excipients Hypromellose (HPMC) / Lactose Anhydrous / Macrogol (PEG) / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Diluent / Plasticizer / Premium Film-Coating (Engineered specifically to form a highly viscous external gel barrier upon swallowing, controlling the exact 24-hour drug diffusion rate) *Pack Sizes: Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 30-day chronic urology dispensing regimens).
Pantoprazole & Domperidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Dual-Release Capsule or Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly acid-labile Pantoprazole and the SR polymer network.
Active Ingredient Strength Primary Clinical Function Pantoprazole Sodium Sesquihydrate USP/Ph.Eur. 40 mg (Enteric-Coated) Global Clinical Standard: Profound, 24-hour suppression of gastric acid production. Domperidone Maleate BP/Ph.Eur. 30 mg (Sustained-Release) Continuous 24-hour peripheral prokinetic action to accelerate gastric emptying and prevent nausea. Excipients Methacrylic Acid Copolymer / Hypromellose (HPMC) / Mannitol / Magnesium Stearate Enteric Barrier Coating / Hydrophilic SR Polymer Matrix / Diluent (Engineered specifically to perfectly isolate the two APIs and control their entirely separate intestinal dissolution rates) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 14-to-28 day chronic gastroenterology dispensing regimens).
Paroxetine Tablets (CR)
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the extended-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 12.5 mg (CR) Initiation Standard: Base titration unit to safely acclimatize the brain and minimize initial side effects. Gold standard for PMDD. Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 25 mg (CR) Global Clinical Standard: Standard adult maintenance dose for Major Depressive Disorder and Severe Panic Disorder. Paroxetine (as HCl Hemihydrate) Ph.Eur./USP 37.5 mg (CR) Advanced Psychiatric Standard: High-dose maintenance therapy for treatment-resistant depression and refractory anxiety. Excipients Hypromellose (HPMC) / Methacrylic Acid Copolymer / Lactose Monohydrate / Magnesium Stearate / Triethyl Citrate Hydrophilic SR Polymer Matrix / Enteric Coating / Diluent / Plasticizer (Engineered to absolutely block stomach acid and control the exact 24-hour intestinal diffusion rate) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic psychiatric dispensing regimens).
Pregabalin SR 75mg +Methylcobalamin 1500mcg Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly light-sensitive B12 coenzyme and the SR polymer network.
Active Ingredient Strength Primary Clinical Function Pregabalin INN/Ph.Eur. 75 mg (Sustained-Release) 24-hour controlled suppression of neuropathic pain and hyperalgesia. Methylcobalamin (Mecobalamin) JP/USP 1500 mcg Global Clinical Standard: High-dose active B12 for the anatomical regeneration of the myelin sheath. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Colloidal Silicon Dioxide / Titanium Dioxide / Magnesium Stearate Hydrophilic SR Polymer Matrix / Diluent / Glidant / UV-Blocking Film-Coating (Engineered to control the exact 24-hour diffusion rate while shielding the API from light degradation) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic diabetology and neurology dispensing regimens).
Ranolazine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the modified-release polymers.
Active Ingredient Strength Primary Clinical Function Ranolazine INN/Ph.Eur. 500 mg (Extended-Release) Global Clinical Standard: Base initiation dose for chronic angina management (taken twice daily). Ranolazine INN/Ph.Eur. 1000 mg (Extended-Release) Advanced maintenance dose for severe, refractory angina requiring maximum cellular relaxation. Excipients Hypromellose (HPMC) / Methacrylic Acid Copolymer / Microcrystalline Cellulose / Magnesium Stearate Hydrophilic Polymer Matrix / Enteric Matrix / Diluent (Engineered to form a viscous gel layer that controls the strict 12-hour drug diffusion rate) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 60 (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Ropinirole ER Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the modified-release polymers.
Active Ingredient Strength Primary Clinical Function Ropinirole HCl USP/Ph.Eur. 2 mg / 4 mg Base titration units for the slow, safe initiation of dopaminergic therapy. Ropinirole HCl USP/Ph.Eur. 8 mg Global Clinical Standard: Advanced maintenance dose for 24-hour continuous symptom control. (Higher total daily doses may be required). Excipients Hypromellose (HPMC) / Carmellose Sodium / Lactose Monohydrate / Magnesium Stearate Hydrophilic Polymer Matrix / Diluent / Lubricant (Engineered to form a viscous gel layer that controls the strict 24-hour drug diffusion rate) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 28/30 (Optimized specifically for strict 30-day chronic neurology dispensing regimens).
